Joseph M Jacob

1.3k total citations
99 papers, 770 citations indexed

About

Joseph M Jacob is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Joseph M Jacob has authored 99 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Surgery, 32 papers in Pulmonary and Respiratory Medicine and 22 papers in Molecular Biology. Recurrent topics in Joseph M Jacob's work include Bladder and Urothelial Cancer Treatments (40 papers), Urinary and Genital Oncology Studies (16 papers) and Renal cell carcinoma treatment (13 papers). Joseph M Jacob is often cited by papers focused on Bladder and Urothelial Cancer Treatments (40 papers), Urinary and Genital Oncology Studies (16 papers) and Renal cell carcinoma treatment (13 papers). Joseph M Jacob collaborates with scholars based in United States, Italy and Netherlands. Joseph M Jacob's co-authors include Gennady Bratslavsky, James E. Lingeman, Naeem Bhojani, Marawan M. El Tayeb, Oleg Shapiro, Jeffrey S. Ross, Andrea Necchi, Glen Kristiansen, Claus Scheidereit and P. Neuhaus and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joseph M Jacob

89 papers receiving 758 citations

Peers

Joseph M Jacob

SURGE

PRM

ONCOL

UROLO

Toshifumi Kurahashi Japan

Spyridon P. Basourakos United States

Jae Young Joung South Korea

Nina Wagener Germany

Debasish Sundi United States

Jacob Korach Israel

Michael Kuettel United States

Earle F. Burgess United States

F M Debruyne Netherlands

Sarah Rudman United Kingdom

Toshifumi Kurahashi Japan

Joseph M Jacob

215 ×0.6

SURGE

476 ×2.0

PRM

228 ×1.0

272 ×1.8

ONCOL

75 ×0.7

UROLO

Citations per year, relative to Joseph M Jacob Joseph M Jacob (= 1×) peers Toshifumi Kurahashi

Countries citing papers authored by Joseph M Jacob

Since Specialization

Citations

This map shows the geographic impact of Joseph M Jacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph M Jacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph M Jacob more than expected).

Fields of papers citing papers by Joseph M Jacob

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph M Jacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph M Jacob. The network helps show where Joseph M Jacob may publish in the future.

Co-authorship network of co-authors of Joseph M Jacob

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph M Jacob. A scholar is included among the top collaborators of Joseph M Jacob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph M Jacob. Joseph M Jacob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Roger, Ashish M. Kamat, Petros Grivas, et al.. (2025). Primary sarcomas of the bladder and prostate: A genomic landscape study. Pathology - Research and Practice. 267. 155840–155840.

Guerrero‐Ramos, Félix, Girish S. Kulkarni, Martin Boegemann, et al.. (2025). 3088P Association of molecular markers with clinical response to TAR-200 in the phase IIb SunRISe-1 trial in patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary disease. Annals of Oncology. 36. S1495–S1496.

Posada, Jessica M., Evgeny Yakirevich, Ashish M. Kamat, et al.. (2024). Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2. Modern Pathology. 37(3). 100424–100424. 8 indexed citations

Jacob, Joseph M, Gennady Bratslavsky, Liang Cheng, et al.. (2024). Urachal (U) and non-urachal (NU) adenocarcinomas (adenoCA) of the bladder: A comparative comprehensive genomic profiling (CGP) study.. Journal of Clinical Oncology. 42(4_suppl). 535–535. 3 indexed citations

Li, Roger, Paras Shah, Tyler F. Stewart, et al.. (2024). Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial. Nature Medicine. 30(8). 2216–2223. 25 indexed citations

Chandrasekar, Thenappan, et al.. (2023). Disparities Associated with Shared Decision-making in Prostate Cancer Screening. European Urology Focus. 9(6). 1008–1015. 2 indexed citations

Yuste, Claudia, Alexandre Carré, Cristina Veres, et al.. (2023). P13.14.A PREDICTION OF OVERALL SURVIVAL IN HIGH-GRADE GLIOMA USING MULTIPARAMETRIC MRI-BASED RADIOMICS. APPLICATION TO A MULTICENTER COHORT. Neuro-Oncology. 25(Supplement_2). ii104–ii104. 1 indexed citations

Peak, Taylor, Philippe E. Spiess, Roger Li, et al.. (2023). Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry. The Oncologist. 28(10). e910–e920. 1 indexed citations

Pavlick, Dean C., Yihong Wang, Benedito A. Carneiro, et al.. (2023). Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy. The Oncologist. 28(7). e508–e519. 9 indexed citations

10.

Zerdan, Maroun Bou, et al.. (2023). Urothelial Bladder Cancer: Genomic Alterations in Fibroblast Growth Factor Receptor. Molecular Diagnosis & Therapy. 27(4). 475–485. 4 indexed citations

11.

Bratslavsky, Gennady, Hanan Goldberg, Andrea Necchi, et al.. (2022). Novel synthetic lethality drug target in urothelial bladder cancer based on MTAP genomic loss. Urologic Oncology Seminars and Original Investigations. 41(2). 109.e15–109.e22. 6 indexed citations

12.

Rompuy, Anne‐Sophie Van, Eduard Roussel, Lien Spans, et al.. (2022). Establishment and Characterization of Advanced Penile Cancer Patient-derived Tumor Xenografts: Paving the Way for Personalized Treatments. European Urology Focus. 8(6). 1787–1794. 9 indexed citations

13.

Heijden, Michiel S. van der, et al.. (2021). SunRISe-1: phase 2b study of TAR-200 plus cetrelimab, TAR-200 alone, or cetrelimab alone in participants with high-risk non-muscle-invasive bladder cancer unresponsive to bacillus Calmette–Guérin who are ineligible for or decline radical cystectomy. European Urology Open Science. 33. S389–S390. 2 indexed citations

14.

Bratslavsky, Gennady, Joseph M Jacob, Thomas Sanford, et al.. (2021). Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 39(6). 367.e1–367.e5. 12 indexed citations

15.

Heijden, Michiel S. van der, Milin Acharya, Neil Beeharry, et al.. (2021). 719TiP SunRISe-1: Phase IIb study of TAR-200 in combination with cetrelimab (CET), TAR-200 alone, or CET alone in participants with high risk non-muscle invasive bladder cancer unresponsive to intravesical bacillus Calmette-Guérin who are ineligible for or elected not to undergo radical cystectomy. Annals of Oncology. 32. S723–S724. 2 indexed citations

16.

Necchi, Andrea, Gennady Bratslavsky, Oleg Shapiro, et al.. (2019). Genomic features of metastatic testicular sex cord stromal tumors.. Journal of Clinical Oncology. 37(7_suppl). 532–532. 11 indexed citations

17.

Calaway, Adam, Dibson Gondim, Chandra K. Flack, et al.. (2017). Anatomic comparison of traditional and enucleation partial nephrectomy specimens. Urologic Oncology Seminars and Original Investigations. 35(5). 221–226. 11 indexed citations

18.

Jacob, Joseph M, Clint Cary, Song Jiang, Richard S. Foster, & Michael G. House. (2016). Management of Duodenal Involvement During Retroperitoneal Lymph Node Dissection for Germ Cell Tumors. Urology. 99. 169–173. 2 indexed citations

19.

Jacob, Joseph M. (1992). The Debates behind an Act: Crown Proceedings Reform. Public law. 452–484. 1 indexed citations

20.

Jacob, Joseph M. (1991). Lawyers go to Hospital. Public law. 255–281. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact